Molecular Imaging: Page 100

ESGAR: Functional imaging progresses in neuroendocrine tumors

By Philip Ward

Diagnosing neuroendocrine tumors can be difficult, but the task is becoming easier due to hybrid PET/CT using new tracers such as gallium-68 DOTA peptides. The technique demonstrates high sensitivity, specificity, and accuracy; has good spatial resolution; and is having a direct impact on clinical management.

June 17, 2012

Identifying top trends in Europe's nuclear medicine market

By Anthony Stevens, PhD

The number of diagnostic nuclear medicine procedures (excluding PET) performed in France, Germany, Italy, Spain, and the U.K. rose by about 1% a year between 2007 and 2011, and France showed the highest level of growth in terms of patient numbers.

June 17, 2012

German team collects SNM Image of the Year award

By Wayne Forrest

German researchers have received this year's Image of the Year award at the recent Society of Nuclear Medicine (SNM) annual meeting for their research illustrating the effectiveness of a new radiopharmaceutical for treating digestive tumors.

June 17, 2012

SNM: PET/CT predicts colorectal cancer outcomes

By AuntMinnieEurope.com staff writers

Careful monitoring of colorectal cancer patients with PET/CT during initial treatment can predict outcomes, potentially improving success rates while reducing treatment costs, Italian researchers reported at this week's Society of Nuclear Medicine (SNM) meeting in Miami Beach, FL.

June 11, 2012

German Cancer Research Center focuses on novel therapies

By Tami Freeman, PhD

Could beams of ion species other than protons and carbon ions prove valuable for particle therapy? This question was posed in a scientific session at last month's annual meeting of the European Society for Radiotherapy and Oncology meeting held in Barcelona.

June 6, 2012

Eckert & Ziegler wins Ga-68 manufacturing authorization

By AuntMinnieEurope.com staff writers

Eckert & Ziegler Radiopharma has obtained manufacturing authorization for pharmaceutical gallium-68 generators, the company said.

June 5, 2012

GE, Affibody to develop PET imaging agent

By AuntMinnieEurope.com staff writers

GE Healthcare and Swedish biopharmaceutical company Affibody are collaborating on the development of a HER2-targeted PET imaging agent for patients with breast or gastric cancer.

June 4, 2012

Imaging market in Eastern Europe to near 2B euros in 2015

By AuntMinnieEurope.com staff writers

The medical imaging market in Central and Eastern Europe and Russia recorded 1.15 billion euros in revenues in 2010 and is expected to reach 1.9 billion euros in 2015, according to market research firm Frost & Sullivan.

May 29, 2012

French survey highlights wide dose discrepancies in PET/CT

By Philip Ward

The results of a national survey of patient dose from whole-body PET/CT systems used in French nuclear medicine departments in 2011 have shown wide variations exist between centers, including fourfold differences in volume CT dose index levels.

May 22, 2012

IsoRay receives CE Mark for GliaSite

By AuntMinnieEurope.com staff writers

Medical isotope developer IsoRay has received the European CE Mark for its GliaSite radiation therapy system.

May 22, 2012

German national congress offers new features and fresh approach

By Frances Rylands-Monk

The German Radiological Society's annual meeting, the DRK, starts in Hamburg tomorrow. Congress president Dr. Hermann Helmberger from Munich plans to "link contradictions" by crossing subjects that within themselves contain a huge variety of different and at times conflicting interests.

May 14, 2012

Siemens makes large modality sale to new U.K. NHS hospital

By AuntMinnieEurope.com staff writers

Siemens Healthcare has completed installation of 10 imaging systems at University Hospital of North Staffordshire NHS Trust in the U.K.

May 3, 2012

Previous Page

Page 100 of 122

Next Page